Compare Duke Energy Corp (DUK) vs Hinge Health Inc. Class A Common Stock (HNGE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Duke Energy Corp vs Hinge Health Inc. Class A Common Stock — how do they compare? Duke Energy Corp trades at $120.99 (market cap $93.28B), while Hinge Health Inc. Class A Common Stock trades at $103.99 (market cap $8.47B). The key difference: Duke Energy Corp is far larger — about 11× Hinge Health Inc. Class A Common Stock's market cap, and Duke Energy Corp pays a 3.63% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Duke Energy Corp for 75 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| DUK | HNGE | |
|---|---|---|
Market Cap | $93.28B | $8.47B |
Volume | 4,666,371 | 1,624,526 |
Sector | Utilities | Health |
52-Week High | $133.46 | $105.14 |
52-Week Low | $113.23 | $31.17 |
Typical Hold Time | 75 Days | 0 Days |
Enterprise Value | $185.79B | $8.09B |
Dividend Yield | 3.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Duke Energy (DUK) trades at $118.19, up 0.42% with a bullish technical signal despite mixed moving averages. The company shows strong fundamentals with consistent earnings beats, 15.78% net margin, and stable dividend payments. Revenue growth from $28.8B in 2022 to $32.2B in 2025 reflects operational strength, though rising debt levels warrant monitoring. Recent news highlights dividend declarations and data center growth opportunities.
DUK presents a balanced outlook with analyst consensus at $131.50 (43.75% buy ratings). Key opportunities include data center demand and dividend reliability, while risks involve rising Treasury yields pressuring utility stocks and increasing debt-to-asset ratio (46.17% in 2025). The stock offers value with a P/E of 17.8 and positive cash flow projections for 2026.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Duke Energy Corp
Duke Energy is one of the largest U.S. utilities, with regulated utilities in the Carolinas, Indiana, Florida, Ohio, and Kentucky that deliver electricity to nearly 8 million customers. Its natural gas utilities serve more than 1.5 million customers. Duke operates in three major segments: electric utilities and infrastructure
Read more on DUK →About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →
